Redcare Pharmacy NV Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,941	2,371	1,799	1,204	1,060
Revenue Growth (YoY)	24.06%	31.79%	49.35%	13.58%	9.53%
Cost of Revenue	2,278	1,825	1,358	872.57	793.53
Gross Profit	663.1	545.8	440.38	331.79	266.8
Selling, General & Admin	683.7	585.1	444.49	379.17	299.21
Other Operating Expenses	-0.5	-0.3	-0.32	-0.15	-0.16
Operating Expenses	683.2	584.8	444.18	379.02	299.05
Operating Income	-20.1	-39	-3.79	-47.23	-32.25
Interest Expense	-19.9	-7.8	-8	-8.5	-8.57
Interest & Investment Income	4.4	6.4	4.61	-	-
Earnings From Equity Investments	0.4	0.4	0.23	0.34	-0.43
Currency Exchange Gain (Loss)	0.4	0.5	0.28	1.76	1.49
Other Non Operating Income (Expenses)	-11.3	-8.4	-7.02	-6.97	-4.53
EBT Excluding Unusual Items	-46.1	-47.9	-13.7	-60.6	-44.28
Merger & Restructuring Charges	-1.9	-	-	-0.32	-
Impairment of Goodwill	-1.3	-	-	-	-
Gain (Loss) on Sale of Investments	-	-	-	-1.58	-0.16
Asset Writedown	-5.2	-	-	-	-
Other Unusual Items	6.8	-	-0.65	-21.62	-33.45
Pretax Income	-47.7	-47.9	-14.35	-84.12	-77.88
Income Tax Expense	-8.3	-1.5	-2.74	-6.47	-3.7
Earnings From Continuing Operations	-39.4	-46.4	-11.61	-77.65	-74.19
Minority Interest in Earnings	1.7	0.9	-0.44	-	-
Net Income	-37.7	-45.5	-12.04	-77.65	-74.19
Net Income to Common	-37.7	-45.5	-12.04	-77.65	-74.19
Shares Outstanding (Basic)	20	20	19	18	18
Shares Outstanding (Diluted)	20	20	19	18	18
Shares Change (YoY)	0.27%	4.24%	6.97%	0.57%	24.37%
EPS (Basic)	-1.87	-2.27	-0.63	-4.32	-4.15
EPS (Diluted)	-1.87	-2.27	-0.63	-4.32	-4.15
Free Cash Flow	-48.3	13.4	55.02	-42.68	-2.18
Free Cash Flow Per Share	-2.40	0.67	2.86	-2.37	-0.12
Gross Margin	22.55%	23.02%	24.48%	27.55%	25.16%
Operating Margin	-0.68%	-1.65%	-0.21%	-3.92%	-3.04%
Profit Margin	-1.28%	-1.92%	-0.67%	-6.45%	-7.00%
Free Cash Flow Margin	-1.64%	0.56%	3.06%	-3.54%	-0.21%
EBITDA	2	-17	14.47	-34	-21.6
EBITDA Margin	0.07%	-0.72%	0.80%	-2.82%	-2.04%
D&A For EBITDA	22.1	22	18.27	13.23	10.65
EBIT	-20.1	-39	-3.79	-47.23	-32.25
EBIT Margin	-0.68%	-1.65%	-0.21%	-3.92%	-3.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.